Secrets to finding the ideal mate:New insights into parameters that govern successful Adeno-associated virus (AAV) vector evolution

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.11588/HEIDOK.00017851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• AAV8 capsid variable regions at the two-fold symmetry axis contribute to high liver transduction by mediating nuclear entry and capsid uncoating.

  2014influential reference
• Peripheral Nerve Injury Modulates Neurotrophin Signaling in the Peripheral and Central Nervous System

  2014cited by this paper
• Current Progress in Gene Delivery Technology Based on Chemical Methods and Nano-carriers

  2014cited by this paper
• Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients With Wiskott-Aldrich Syndrome

  2014cited by this paper
• Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing

  2014cited by this paper
• Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

  2014cited by this paper
• Creation of a cardiotropic adeno-associated virus: the story of viral directed evolution

  2013cited by this paper
• Molecular dissection of human Argonaute proteins by DNA shuffling

  2013influential reference
• Human gene therapy: a brief overview of the genetic revolution.

  2013cited by this paper
• Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain

  2013cited by this paper
• Lipid-based nanoparticles as nonviral gene delivery vectors.

  2013cited by this paper
• Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors

  2013cited by this paper
• Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

  2013cited by this paper
• GENE THERAPY Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-speci fi c CD 8 1 T cells

  2013cited by this paper
• A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype

  2013cited by this paper
• Productive Entry of HIV-1 during Cell-to-Cell Transmission via Dynamin-Dependent Endocytosis

  2013cited by this paper
• Gene therapy clinical trials worldwide to 2012 – an update

  2013cited by this paper
• Differential Adeno-Associated Virus Serotype-Specific Interaction Patterns with Synthetic Heparins and Other Glycans

  2013influential reference
• Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

  2013cited by this paper
• Functional study of dextran-graft-poly((2-dimethyl amino)ethyl methacrylate) gene delivery vector for tumor therapy

  2013cited by this paper
• Immune responses to AAV vectors: overcoming barriers to successful gene therapy.

  2013cited by this paper
• Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors.

  2013cited by this paper
• Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells.

  2012influential reference
• Nuclear translocation of adeno-associated virus type 2 capsid proteins for virion assembly.

  2012cited by this paper
• Adeno-associated virus vectorology, manufacturing, and clinical applications.

  2012cited by this paper
• Properties of the Adeno-Associated Virus Assembly-Activating Protein

  2012influential reference
• Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling.

  2012cited by this paper
• Development and Validation of Novel AAV2 Random Libraries Displaying Peptides of Diverse Lengths and at Diverse Capsid Positions

  2012cited by this paper
• Alleviation of shRNA off-target effects via rAAV vector-encoded sense strand decoys

  2012cited by this paper
• Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue

  2012cited by this paper
• Identification of the Galactose Binding Domain of the Adeno-Associated Virus Serotype 9 Capsid

  2012cited by this paper
• Impact of VP1-Specific Protein Sequence Motifs on Adeno-Associated Virus Type 2 Intracellular Trafficking and Nuclear Entry

  2012cited by this paper
• Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid Uncoating and Genome Release

  2012cited by this paper
• Single Tyrosine Mutation in AAV8 and AAV9 Capsids Is Insufficient to Enhance Gene Delivery to Skeletal Muscle and Heart

  2012cited by this paper
• Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery

  2012cited by this paper
• NIH oversight of human gene transfer research involving retroviral, lentiviral, and adeno-associated virus vectors and the role of the NIH recombinant DNA advisory committee.

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012influential reference
• AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

  2012cited by this paper
• Intracellular transport of recombinant adeno-associated virus vectors

  2012influential reference
• The Threefold Protrusions of Adeno-Associated Virus Type 8 Are Involved in Cell Surface Targeting as Well as Postattachment Processing

  2012cited by this paper
• The AAV Vector Toolkit: Poised at the Clinical Crossroads.

  2012influential reference
• The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes

  2011cited by this paper
• An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells

  2011influential reference
• The human visual cortex responds to gene therapy-mediated recovery of retinal function.

  2011cited by this paper
• Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.

  2011cited by this paper
• Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway.

  2011cited by this paper
• MicroRNA-Restricted Transgene Expression in the Retina

  2011cited by this paper
• The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice.

  2011cited by this paper
• Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders

  2011influential reference
• Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 Vectors

  2011cited by this paper
• microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors

  2011cited by this paper
• Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo

  2011cited by this paper
• Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.

  2011cited by this paper
• Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery.

  2011cited by this paper
• Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis

  2011cited by this paper
• Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.

  2011influential reference
• Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking

  2011influential reference
• AAV capsid structure and cell interactions.

  2011influential reference
• Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity

  2011cited by this paper
• Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9*

  2011cited by this paper
• Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles.

  2011cited by this paper
• Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

  2011cited by this paper
• Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors

  2011cited by this paper
• Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library

  2010influential reference
• Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors

  2010cited by this paper
• A viral assembly factor promotes AAV2 capsid formation in the nucleolus

  2010cited by this paper
• Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB).

  2010influential reference
• Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

  2010cited by this paper
• Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6

  2010cited by this paper
• A NEW RECOMBINANT ADENO-ASSOCIATED VIRUS (AAV)-BASED RANDOM PEPTIDE DISPLAY LIBRARY SYSTEM: INFECTION-DEFECTIVE AAV1.9-3 AS A NOVEL DETARGETED PLATFORM FOR VECTOR EVOLUTION.

  2010cited by this paper
• Transfection efficiency of cationic lipids with different hydrophobic domains in gene delivery.

  2010cited by this paper
• Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction

  2010cited by this paper
• Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

  2010influential reference
• Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

  2010cited by this paper
• Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver

  2010cited by this paper
• Directed evolution of adeno-associated virus for glioma cell transduction

  2010cited by this paper
• The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion.

  2010cited by this paper
• Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle

  2010cited by this paper
• Chimeric AAV Cap sequences alter gene transduction.

  2009cited by this paper
• Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide Libraries

  2009cited by this paper
• Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses.

  2009cited by this paper
• DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.

  2009cited by this paper
• Enhancing transduction of the liver by adeno-associated viral vectors

  2009cited by this paper
• Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues

  2009influential reference
• Heparin binding induces conformational changes in Adeno-associated virus serotype 2.

  2009cited by this paper
• Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus

  2009cited by this paper
• Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.

  2009cited by this paper
• Molecular evolution of adeno-associated virus for enhanced glial gene delivery.

  2009cited by this paper
• HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

  2009cited by this paper
• Directed evolution of adeno-associated virus to an infectious respiratory virus

  2009cited by this paper
• Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex.

  2009cited by this paper
• Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts.

  2009cited by this paper
• Adeno-associated viral vectors and their redirection to cell-type specific receptors.

  2009influential reference
• A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection

  2009influential reference
• Adenovirus receptors and their implications in gene delivery

  2009cited by this paper
• Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies.

  2009cited by this paper
• Long term culture of normal and neoplastic human glia.

  2009cited by this paper
• Advances in gene delivery through molecular design of cationic lipids.

  2009cited by this paper
• Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

  2009cited by this paper
• Definition of Herpes Simplex Virus Type 1 Helper Activities for Adeno-Associated Virus Early Replication Events

  2009cited by this paper

• Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver artificial primary microrna mimics

  2015cites this paper